Background As a core component of the human intestinal microecosystem, the gut microbiota has been increasingly recognized for its pivotal role in colorectal cancer (CRC), a global
This is a narrative review synthesizing existing knowledge about ion channel pharmacology and emerging technologies; it raises questions about therapeutic potential rather than reporting new empirical evidence or clinical outcomes.